A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa.
Phase of Trial: Phase II
Latest Information Update: 11 May 2017
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors IMPAX Laboratories
- 25 Apr 2015 Results of pooled analysis of 7 phase II and III studies presented at the 67th Annual Meeting of the American Academy of Neurology.
- 13 Jul 2011 Results published in the Movement Disorders.
- 14 Apr 2010 Results presented at the 62nd Annual Meeting of the American Academy of Neurology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History